Analysis of posttreatment biopsies from metastatic lesions revealed a relation between the extent of therapy-induced tumor necrosis and the natural logarithm of the ratio of tumor-infiltrating CD8+ effector T cells to Treg cells, suggesting that ipilimumab can alter the balance of effector T cells and Treg cells (31). The gene discussed is CD8A; the disease is neoplasm.